Lincoln Pharma.

42
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
511.05
-0.85 (-0.17%)
BSENSE

Nov 20

BSE+NSE Vol: 16.09 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
671.00
623.00
580.00
510.00
472.00
424.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
671.00
623.00
580.00
510.00
472.00
424.00
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
8.00
-5.00
-4.00
-13.00
3.00
Raw Materials Consumed
318.00
282.00
284.00
245.00
232.00
193.00
Power & Fuel Cost
11.00
11.00
11.00
10.00
8.00
7.00
Employee Cost
125.00
112.00
102.00
93.00
79.00
63.00
Operating Expenses
31.00
27.00
23.00
18.00
16.00
15.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
35.00
28.00
23.00
18.00
16.00
24.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
4.00
3.00
3.00
2.00
2.00
1.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
573.00
521.00
480.00
421.00
376.00
337.00
Operating Profit (PBDIT) excl Other Income
97.00
101.00
99.00
89.00
95.00
87.00
Other Income
33.00
22.00
34.00
22.00
9.00
5.00
Operating Profit (PBDIT)
131.00
123.00
134.00
111.00
105.00
92.00
Interest
1.00
1.00
1.00
2.00
1.00
1.00
Profit before Depriciation and Tax
130.00
122.00
132.00
109.00
104.00
91.00
Depreciation
14.00
12.00
10.00
9.00
8.00
7.00
Profit Before Taxation & Exceptional Items
115.00
109.00
122.00
100.00
95.00
83.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
115.00
109.00
122.00
100.00
95.00
83.00
Provision for Tax
27.00
26.00
28.00
27.00
26.00
21.00
Profit After Tax
87.00
82.00
93.00
72.00
69.00
62.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
585.00
507.00
417.00
348.00
282.00
220.00
Profit Available for appropriations
673.00
589.00
510.00
421.00
351.00
282.00
Appropriations
673.00
589.00
510.00
421.00
351.00
282.00
Equity Dividend (%)
18.00%
18.00%
18.00%
15.00%
15.00%
15.00%
Earnings Per Share
43.88
41.11
46.58
36.40
34.63
31.08
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 7.67% vs 7.35% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -3.75% vs 1.59% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -46.20% vs 28.53% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 6.74% vs -11.74% in Mar 2025

Compare Profit and Loss Results of Lincoln Pharma.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
671.00
0
671.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
671.00
0
671.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
0
-7.00
0%
Raw Materials Consumed
318.00
0
318.00
0%
Power & Fuel Cost
11.00
0
11.00
0%
Employee Cost
125.00
0
125.00
0%
Operating Expenses
31.00
0
31.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
35.00
0
35.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
4.00
0
4.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
573.00
0
573.00
0%
Operating Profit (PBDIT) excl Other Income
97.00
0.00
97.00
0%
Other Income
33.00
0
33.00
0%
Operating Profit (PBDIT)
131.00
0
131.00
0%
Interest
1.00
0
1.00
0%
Profit before Depriciation and Tax
130.00
0
130.00
0%
Depreciation
14.00
0
14.00
0%
Profit Before Taxation & Exceptional Items
115.00
0
115.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
115.00
0
115.00
0%
Provision for Tax
27.00
0
27.00
0%
Profit After Tax
87.00
0
87.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
585.00
0
585.00
0%
Profit Available for appropriations
673.00
0
673.00
0%
Appropriations
673.00
0
673.00
0%
Equity Dividend (%)
18%
0%
18.00
Earnings Per Share
43.88
0
43.88
0%
Profit And Loss - Net Sales
Net Sales 671.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 7.67% vs 7.35% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 97.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.75% vs 1.59% in Mar 2025

Profit And Loss - Interest
Interest 1.01 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -46.20% vs 28.53% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 87.89 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.74% vs -11.74% in Mar 2025